In order to investigate the contribution of the multidrug efflux pumps to cellular resistance to a variety of agents including cationic surfactants, we cloned genes of major drug efflux pumps of Escherichia coli and transformed strain JM109 with plasmids encoding those genes.
Surfactants as amphipathic compounds have been utilized in a variety of fields, such as chemical, pharmaceutical and food industries, hospitals, homes, and environments for cleaning, emulsification, solubilization, moisturizing and so on (Schwartz and Perry, 1979) . In particular, cationic surfactants have antimicrobial activity (Hugo and Russell, 1992; Schwartz and Perry, 1979) and are therefore widely used in hospitals and food industries as disinfectants or sanitizers. As for the mode of action, they have been reported to disrupt cell membranes (Scharff and Maupin, 1960) , interrupt protein functions (Putnam, 1948) , release intracellular K+ and other constituents (Cabral, 1993; Sakagami et al., 1989) , inhibit cellular respiration (Majtan et al., 1995) and induce cell autolysis (Cho et al., 1990; Tsuchido et al., 1990) . However, several investigators have isolated so far cationic surfactant resistant-bacteria from a variety of niches (Heir et al., 1995 (Heir et al., , 1998 (Heir et al., and 1999 Kiicken et al., 2000; Lemaitre et al., 1998; Littlejohn et al., 1992; Nagai et al., 1996; Sakagami et al., 1989) .
Major ways that bacterial cells acquire drug resistance are as follows: i) inactivation of the drug, ii) characteristic or quantitative change of the target of the drug, iii) depression of drug permeation and iv) active drug efflux (Davies, 1994) . Among these ways, drug efflux from cells has recently been actively investigated and many membrane translocators have been found as efflux pumps. Their function is known to confer multidrug resistance to bacterial cells (Lewis, 1994; Nikaido, 1994 and 1996) . Such drug efflux pumps can extrude a variety of agents, including antibiotics, surfactants, oxidative phosphorylation uncouplers, and oxidants from cells. Lacroix et al. (1996 and 1995) have found that an acrB-like gene confers not only multiple antibiotic resistance but also multiple surfactant resistance on Salmonella typhimurium cells. Several investigators have also reported that overproduction of drug efflux pumps increases cellular resistance to various agents including surfactants (Edgar and Bibi, 1997; Jack et al., 2000; Neyfakh et al., 1991) . We have also isolated and characterized a cationic surfactant resistant strain of Escherichia coli and found that the strain has an altered cell envelope compared to its parent strain (Ishikawa et al., 2002) . In this study, to investigate a possible contribution of increased numbers of efflux pump genes to the cellular resistance to a variety of agents including cationic surfactants, we cloned genes of major drug efflux pumps referred to in GenBank, emrAB (AE000152), emrD (AE000445), mdfA (cmr; AE000186), emrE (mvrC; AE000160) and envCD (acrEF; AE000405), from the chromosomal DNA of E. coli, and then examined how much efflux pump gene-recombinants of E. coli increase their resistance to cationic surfactants and some other agents.
Genes of drug efflux pumps of F coli including their original promoters and terminators amplified by the PCR method were cloned in multi-cloning sites of pUC18/ 19 or pHSG575 ( a Substrates were referred to in reports by Nikaido (1994 and 1996) . Abbreviations: NAX, Nalidixic acid;
Cm, chioramphenicol; Tc, tetracycline; Em, erythromycin; BC, benzalkonium chloride; CV, crystal violet; EB, ethidium bromide; PQ, paraquat; TPP, tetraphenylphosphonium; Ap, ampicillin; SDS, sodium dodecyl sulfate. (Table 3 and data not shown). In the turbidity monitoring, however, the mdfA-and emrE-recombinants grew after a short lag even in the presence of 15 ki M CTAB, whereas the parental strain did not (Fig. 2D) . It is generally considered that the activity of the drug efflux pump directly corresponds to the degree of cellular drug resistance (Nikaido, 1994 and 1996) . In fact, in this study, the mdfA-and emrE-recombinants were demonstrated to have multidrug resistance. However, no marked multidrug resistance was observed in each recombinant tested here. One possible reason may be due to the nature of the host strain JM109 itself. This strain has a full set of genes of drug efflux pumps, including genes used in this study, on its chromosome. We infer that the drug resistance of strain JM109 is relatively high and this high basal resistance may mask an increase in drug resistance mediated by each amplified gene of pump. In fact, when an acrAB mutant of E. coil, which has low basal resistance, is used to clone efflux pump genes, markedly increased resistance has been obtained (Masaoka et al., 2000; Mine et al., 1999; Morita et al.,1998) .
Very recently, characterization of knock-out mutants (Sulavik et al., 2001 ) and overproducing strains (Nishino and Yamaguchi, 2001 ) of various drug efflux genes in E coli have been investigated. However, it remains unclear whether and how those genes are involved in the appearance of drug resistant bacteria like those isolated from hospitals or food industries.
We have isolated a CTAB-resistant mutant from E. coli and reported that the mutant was multidrug resistant (Ishikawa et al., 2002) . We cloned the same sets of drug efflux pumps described here from the mutant and investigated the degree of increased resistance of recombinants having those genes. However, the effect of gene dosage efflux pump genes derived from this mutant were the same level as those derived from the parent strain OW6 (data not shown). In this mutant, therefore, it is suggested that some mechanism other than drug efflux may also work for its multidrug resistance.
Recently, several mutants resistant to sanitizers including cationic surfactants have been isolated and some of them were characterized to possess multiple antibiotic resistant property (Akimitsu et al., 1999; Ishikawa et al., 2002; Tattawasart et al., 1999 ). This finding predicts a possible risk upon resulting from continuous use of surfactants, that is, the occurrence of multidrug resistant mutants from bacteria inhabiting various niches. Moreover, Miyamae et al. (1998) have reported a norfloxacin-resistant mutant of Bacteroides fragilis isolated spontaneously which increased its resistances not only to several antibiotics but also to CTAB. The cross resistance between sanitizers including surfactants and antibiotics does not seem to be a peculiar phenomenon, since bacteria easily acquire multidrug resistance, as exemplified previously (Ishikawa et al., 2002) . In the near future, these mutants might become a serious environmental problem in human life. In order to under stand the detailed mechanisms of bacterial multidrug resistance, further studies are necessary. 
